Altria Inc

$39.00

SKU: MO-1 Category:

Description

Altria’s recent first-quarter performance was tepid and was adversely impacted by a reduction in shipment volumes in the smokable category. Moreover, the US FDA’s plans on banning menthol-flavored cigarettes can act as a mega headwind for the company’s future growth and may lead to a drop in cigarette volume sold by Altria in the future quarters. Nevertheless, the company’s oral tobacco and wine segments have performed well recently due to improved pricing. In addition, shipment volumes in the oral tobacco unit, supported by growth in on! nicotine pouches have seen significant traction. Altria now has full global ownership of on! oral nicotine pouches given its recently closed transaction to acquire the remaining 20% global interest for approximately $250 million. To sum up, despite Altria’s recent macro challenges, we believe that the stock deserves a ‘Hold’ rating.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $496 annual subscription!

Menu